Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cancer science

Showing results (1-10 of 7,104) with videos related to

Pageof 711
Sort By:
Cancer Science|August 7, 2003
Differential gene expression profiles in colon epithelium of two rat strains with distinct susceptibility to colon carcinogenesis after exposure to PhIP in combination with dietary high fatKyoko Fujiwara, Masako Ochiai, Tsuneyuki Ubagai, et al.
Cancer Science|August 7, 2003
Repeated hepatocyte injury promotes hepatic tumorigenesis in hepatitis C virus transgenic miceTakanobu Kato, Michiko Miyamoto, Tomoko Date, et al.
Cancer Science|August 7, 2003
DNA hypermethylation and histone hypoacetylation of the HLTF gene are associated with reduced expression in gastric carcinomaYoichi Hamai, Naohide Oue, Yoshitsugu Mitani, et al.
Cancer Science|August 7, 2003
The implication of background anthracosis in the development and progression of pulmonary adenocarcinomaDaye Wang, Yuko Minami, Yujian Shu, et al.
Cancer Science|July 5, 2003
Intraperitoneal radioimmunotherapy in treating peritoneal carcinomatosis of colon cancer in mice compared with systemic radioimmunotherapySeigo Kinuya, Xiao-Feng Li, Kunihiko Yokoyama, et al.
Cancer Science|June 11, 2022
Phase I study of alvocidib plus cytarabine/mitoxantrone or cytarabine/daunorubicin for acute myeloid leukemia in JapanTakayuki Ikezoe, Kiyoshi Ando, Masahiro Onozawa, et al.
Cancer Science|June 14, 2022
Antitumoral RNA-targeted oligonucleotide therapeutics: The third pillar after small molecule inhibitors and antibodiesHiroaki Taniguchi, Yasunori Suzuki, Kohzoh Imai, et al.
Cancer Science|June 14, 2022
RITA1 drives the growth of bladder cancer cells by recruiting TRIM25 to facilitate the proteasomal degradation of RBPJHuancheng Tang, Xiangdong Li, Lijuan Jiang, et al.
Cancer Science|January 29, 2011
Curcumin analog GO-Y030 is a novel inhibitor of IKKβ that suppresses NF-κB signaling and induces apoptosisAtsuko Sato, Chieko Kudo, Hiroyuki Yamakoshi, et al.
Cancer Science|January 29, 2011
Efficacy of gefitinib for non-adenocarcinoma non-small-cell lung cancer patients harboring epidermal growth factor receptor mutations: a pooled analysis of published reportsTakehito Shukuya, Toshiaki Takahashi, Rieko Kaira, et al.
Pageof 711

Showing results (1-10 of 7,104) with videos related to

Sort By:
Pageof 711
Cancer Science|August 7, 2003
Differential gene expression profiles in colon epithelium of two rat strains with distinct susceptibility to colon carcinogenesis after exposure to PhIP in combination with dietary high fatKyoko Fujiwara, Masako Ochiai, Tsuneyuki Ubagai, et al.
Cancer Science|August 7, 2003
Repeated hepatocyte injury promotes hepatic tumorigenesis in hepatitis C virus transgenic miceTakanobu Kato, Michiko Miyamoto, Tomoko Date, et al.
Cancer Science|August 7, 2003
DNA hypermethylation and histone hypoacetylation of the HLTF gene are associated with reduced expression in gastric carcinomaYoichi Hamai, Naohide Oue, Yoshitsugu Mitani, et al.
Cancer Science|August 7, 2003
The implication of background anthracosis in the development and progression of pulmonary adenocarcinomaDaye Wang, Yuko Minami, Yujian Shu, et al.
Cancer Science|July 5, 2003
Intraperitoneal radioimmunotherapy in treating peritoneal carcinomatosis of colon cancer in mice compared with systemic radioimmunotherapySeigo Kinuya, Xiao-Feng Li, Kunihiko Yokoyama, et al.
Cancer Science|June 11, 2022
Phase I study of alvocidib plus cytarabine/mitoxantrone or cytarabine/daunorubicin for acute myeloid leukemia in JapanTakayuki Ikezoe, Kiyoshi Ando, Masahiro Onozawa, et al.
Cancer Science|June 14, 2022
Antitumoral RNA-targeted oligonucleotide therapeutics: The third pillar after small molecule inhibitors and antibodiesHiroaki Taniguchi, Yasunori Suzuki, Kohzoh Imai, et al.
Cancer Science|June 14, 2022
RITA1 drives the growth of bladder cancer cells by recruiting TRIM25 to facilitate the proteasomal degradation of RBPJHuancheng Tang, Xiangdong Li, Lijuan Jiang, et al.
Cancer Science|January 29, 2011
Curcumin analog GO-Y030 is a novel inhibitor of IKKβ that suppresses NF-κB signaling and induces apoptosisAtsuko Sato, Chieko Kudo, Hiroyuki Yamakoshi, et al.
Cancer Science|January 29, 2011
Efficacy of gefitinib for non-adenocarcinoma non-small-cell lung cancer patients harboring epidermal growth factor receptor mutations: a pooled analysis of published reportsTakehito Shukuya, Toshiaki Takahashi, Rieko Kaira, et al.
Pageof 711